The estrogen receptor and progesterone receptor are proteins directly related to BC, and, in combination with HER-2/neu gene amplification, they are used for the classification of TNBC, a very aggressive and metastatic subtype that lacks the above three significant molecular markers [85,87]. Here, ERBB2 is linked to breast cancer.